GENEVA, June 26 -- INNOVENT BIOLOGICS (SUZHOU) CO., LTD. filed a patent application (CN2025/139999) for “PREPARATION OF ANTI-GPRC5D/BCMA/CD3 TRISPECIFIC ANTIBODY AND USE THEREOF”. With publication no. WO/2026/119236, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: C07K 19/00
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....